Tofacitinib Does Not Increase Risk of Venous Thromboembolism in Patients With RA
Question Does Tofacitinib Increase the Risk of Venous Thromboembolism in Patients with RA? Conclusion Recently, a link between venous thromboembolism (VTE) and Janus Kinase (JAK) inhibitors has emerged, causing the FDA to recommend a black box label for tofacitinib in…